Utah Retirement Systems Agios Pharmaceuticals, Inc. Transaction History

Utah Retirement Systems

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $313,567 - $479,835	-9,678 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $8,587 - $12,666	186 Added 1.96%	9,678 $483,000
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $4,224 - $6,225	92 Added 0.98%	9,492 $641,000
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $14,644 - $19,910	200 Added 2.17%	9,400 $792,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $89,745 - $129,795	1,500 Added 19.48%	9,200 $753,000
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $5,212 - $7,233	100 Added 1.32%	7,700 $440,000
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $417,164 - $510,112	7,600	7,600 $507,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.